Sandbox:Pertussis laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
There are differences in the diagnostic needs of the clinical versus the public health setting. In the clinical setting, the goal is to optimize [[sensitivity]] while providing rapid results. This ensures rapid diagnosis and appropriate treatment to prevent further transmission. In the public health setting, a high degree of [[specificity]] is needed to avoid unnecessary and ineffective public health interventions.  Several types of laboratory tests are commonly used for the diagnosis of [[Bordetella pertussis]]. Culture is considered the gold standard because it is the only 100% specific method for identification. Other tests that can be performed include [[polymerase chain reaction]] (PCR) and serology.
Several types of laboratory tests are commonly used to diagnose Pertussis. Culture, obtained by nasopharyngeal swab, is considered the gold standard because it is the only 100% specific method for identification. Other tests that can be performed include [[polymerase chain reaction]] (PCR) and serology.


==Laboratory Findings==
==Laboratory Findings==
Line 13: Line 13:
**Nasopharyngeal aspirates should be dispensed and plated within 24 hours of collection.  
**Nasopharyngeal aspirates should be dispensed and plated within 24 hours of collection.  
**The same specimen can be used both for culture and [[polymerase chain reaction]] (PCR).  
**The same specimen can be used both for culture and [[polymerase chain reaction]] (PCR).  
**With PCR, the most rapid test, the specimen should ideally be collected during the first three weeks of illness, but may provide accurate results for up to 4 weeks.


===Culture===
===Culture===


*Since culture has excellent specificity, it is particularly useful for confirming pertussis diagnosis when an outbreak is suspected, differentiating it from other respiratory pathogens with similar clinical symptoms and possibility of co-infection.  
*Since culture has 100% specificity, it is particularly useful for confirming pertussis diagnosis when an outbreak is suspected, differentiating it from other respiratory pathogens with similar clinical symptoms and possibility of co-infection.<ref name=CDC4>[http://www.cdc.gov/pertussis/clinical/diagnostic-testing/diagnosis-confirmation.html Pertussis (whooping coug). Diagnosis confirmation. CDC.gov. Accessed on June 15, 2014]</ref>
**Obtaining isolates from culture allows for strain identification of [[Bordetella pertussis]] and [[antimicrobial resistance]] testing.  
**Obtaining isolates from culture allows for strain identification of [[Bordetella pertussis]] and [[antimicrobial resistance]] testing.  
*Culture testing has advantageous specificity to Naspharyngeal Swabs, but is less rapid and takes up to seven days to display results.
*Culture testing has advantageous specificity to Naspharyngeal Swabs, but is less rapid and takes up to seven days to display results.
*Culture is best done from nasopharyngeal specimens collected during the first 2 weeks of cough when viable bacteria are still present in the [[nasopharynx]].  
*Culture is best done from nasopharyngeal specimens collected during the first 2 weeks of cough when viable bacteria are still present in the [[nasopharynx]].  
*The [[bacteria]] can be recovered from the patient only during the first three weeks of illness, rendering culturing useless after this period.
*The [[bacteria]] can be recovered from the patient only during the first three weeks of illness, rendering culturing useless after this period.
**[[Sensitivity]] is decreased and the risk of false-negatives increases after the first 2 weeks.<ref name=CDC4>[http://www.cdc.gov/pertussis/clinical/diagnostic-testing/diagnosis-confirmation.html Pertussis (whooping coug). Diagnosis confirmation. CDC.gov. Accessed on June 15, 2014]</ref>
**[[Sensitivity]] is decreased and the risk of false-negatives increases after the first 2 weeks.


===PCR===
===PCR===

Revision as of 19:41, 12 January 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]; Rim Halaby, M.D. [3]

Pertussis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pertussis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sandbox:Pertussis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sandbox:Pertussis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sandbox:Pertussis laboratory findings

CDC onSandbox:Pertussis laboratory findings

Sandbox:Pertussis laboratory findings in the news

Blogs on Sandbox:Pertussis laboratory findings

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Sandbox:Pertussis laboratory findings

Overview

Several types of laboratory tests are commonly used to diagnose Pertussis. Culture, obtained by nasopharyngeal swab, is considered the gold standard because it is the only 100% specific method for identification. Other tests that can be performed include polymerase chain reaction (PCR) and serology.

Laboratory Findings

Nasopharyngeal Swab

  • Whenever possible, a nasopharyngeal swab or aspirate should be obtained from all suspected Pertussis patients for the best chance to obtain the most accurate diagnosis.[1]
  • If culture is planned: Once a nasopharyngeal swab has been collected it should be plated directly or placed into transport medium immediately.[1]
    • Nasopharyngeal aspirates should be dispensed and plated within 24 hours of collection.
    • The same specimen can be used both for culture and polymerase chain reaction (PCR).

Culture

  • Since culture has 100% specificity, it is particularly useful for confirming pertussis diagnosis when an outbreak is suspected, differentiating it from other respiratory pathogens with similar clinical symptoms and possibility of co-infection.[2]
  • Culture testing has advantageous specificity to Naspharyngeal Swabs, but is less rapid and takes up to seven days to display results.
  • Culture is best done from nasopharyngeal specimens collected during the first 2 weeks of cough when viable bacteria are still present in the nasopharynx.
  • The bacteria can be recovered from the patient only during the first three weeks of illness, rendering culturing useless after this period.
    • Sensitivity is decreased and the risk of false-negatives increases after the first 2 weeks.

PCR

  • PCR is a rapid test with excellent sensitivity; however, PCR tests can vary in specificity and it is therefore recommended to obtaine culture confirmation for at least one case for any suspicion of a pertussis outbreak.
  • PCR should be tested from nasopharyngeal specimens taken at 0-3 weeks following cough onset, but may provide accurate results for up to 4 weeks.
    • After the fourth week of cough, the amount of bacterial DNA rapidly diminishes, which increases the risk of obtaining falsely-negative results.
  • PCR assay protocols that include multiple target sequences allow for speciation among Bordetella species.
  • The high sensitivity of PCR increases the risk of false-positivity, but following some simple best practices can reduce the risk of obtaining inaccurate results.[2]

Serology

  • The CDC and FDA have developed a serologic assay that has been extremely useful for confirming pertussis diagnosis, especially during suspected outbreaks.[2]
    • Many State Public Health Labs have include this assay as part of their testing regimen.
  • Serologic tests are generally more useful for diagnosis in later phases of the disease:
    • CDC single point serology: the optimal timing for specimen collection is 2 to 8 weeks following cough onset, when the antibody titers are at their highest.
  • Serology may still be performed on specimens collected up to 12 weeks following cough onset.
  • Serology is often used to determine whether antibody against pertussis toxin or another component of Bordetella pertussis is present at high levels in the blood of the patient in the case of adolescents and adults that do not often seek medical care until several weeks into the illness.[2]

Depicted below is an image of the optimal timing for the different tests used for the diagnosis of pertussis.

Pertussis

[2]

References

Template:WH Template:WS